PHARMA-TECH A/S: Financial statements 2021
CVR: 32940897
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
PHARMA-TECH A/S (CVR 32940897) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 18,037,787 and a net result of DKK 3,111,043 compared with DKK 11,868,450 the year before. That is a decrease of 37.7% compared with the year before. Equity in the 2021 report amounted to DKK 17,431,427. The solvency ratio was 60.8%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 18,037,787
- Profit/Loss
- DKK 3,111,043
- Equity
- DKK 17,431,427
- Total Assets
- DKK 28,659,737
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 18 mio. | 3.1 mio. | 17.4 mio. | 21 |
| 2020 | - | 29 mio. | 11.9 mio. | 22.3 mio. | 21 |
| 2019 | - | 15.3 mio. | 3.5 mio. | 10.5 mio. | 20 |
| 2018 | - | 14.7 mio. | 3.7 mio. | 8.9 mio. | 19 |
| 2017 | - | 13.3 mio. | 3.4 mio. | 8.3 mio. | 17 |
Official annual report
Find more companies like PHARMA-TECH A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of April 7, 2021, Karina Rubek has joined the board of directors of PHARMA-TECH A/S.
As of April 7, 2021, Ole Gade has left the board of directors of PHARMA-TECH A/S.
PHARMA-TECH A/S has published its annual report for 2020. Gross profit came to DKK 28,973,160, and the net result was DKK 11,868,450.
About PHARMA-TECH A/S
PHARMA-TECH A/S is a Danish company of the type Aktieselskab based in Randers SV, founded in 2010. The company is registered under the industry Fremstilling af plastemballage. The management consists of Morten Hart Johansen. The board consists of Claus Wædeled (chair), Morten Hart Johansen and Rikke Winther. The company is owned by JoWin Holding ApS. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 32,243,339 and a net result of DKK 5,636,893 compared with DKK 6,599,234 the year before. Equity in the 2025 report amounted to DKK 24,456,581.